
HBV
HBV inhibitors are compounds designed to target and inhibit various stages of the Hepatitis B virus (HBV) lifecycle. These inhibitors can interfere with viral replication, assembly, or release, thereby reducing the viral load and helping to manage chronic HBV infections. Research into HBV inhibitors is crucial for developing effective antiviral therapies to prevent liver disease and cancer associated with HBV. At CymitQuimica, we offer a range of HBV inhibitors to support your research in virology, antiviral drug development, and infectious disease management.
Found 176 products of "HBV"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Pradefovir
CAS:<p>Pradefovir (Remofovir) is a prodrug for chronic HBV, converting to PMEA in the liver with a Km of 60 μM and clearance of 359 ml/min.</p>Formula:C17H19ClN5O4PPurity:97.50%Color and Shape:SolidMolecular weight:423.79HBV-IN-8
CAS:<p>HBV-IN-6 is a potent inhibitor of HBV (EC50: 287.9 nM).</p>Formula:C21H25ClFN5O5S2Color and Shape:SolidMolecular weight:546.04HBF-0259
CAS:<p>HBF-0259 is an inhibitors of hepatitis B virus surface antigen (HBsAg) secretion with an EC50 of 11.3 μM and a CC50 value of >50 μM in HepG2.2.15 cells.</p>Formula:C16H12Cl2FN5Purity:98.07% - 99.42%Color and Shape:SolidMolecular weight:364.2HBV-IN-13
CAS:<p>HBV-IN-12 is a potent inhibitor of hepatitis B surface antigen (HBsAg).</p>Formula:C22H25NO7Color and Shape:SolidMolecular weight:415.44HEC72702
CAS:<p>HEC72702: New HBV capsid inhibitor, from GLS4. No CYP1A2, CYP3A4, CYP2B6 induction at 10μM.</p>Formula:C24H26BrFN4O5SColor and Shape:SolidMolecular weight:581.45HBV-IN-17
CAS:<p>HBV-IN-17 (compound 8) is a potent regulator of HBV capsid assembly (EC50: 511 nM).</p>Formula:C17H15F6N5O2Color and Shape:SolidMolecular weight:435.32Oxynitidine
CAS:<p>Oxynitidine, an HBV inhibitor (ID50 = 30.8 µg/mL), effectively suppresses HBV DNA replication and may be utilized in viral infection research [1].</p>Formula:C21H17NO5Purity:98%Color and Shape:SolidMolecular weight:363.36HBV-IN-41
CAS:<p>HBV-IN-41 (compound 45) is a potent, orally active inhibitor of Hepatitis B Virus (HBV), exhibiting an EC50 value of 0.027μM [1].</p>Formula:C18H19ClFN5O3Purity:98%Color and Shape:SolidMolecular weight:407.83Emtricitabine triphosphate tetrasodium salt
CAS:<p>Emtricitabine triphosphate tetrasodium salt is the tetrasodium salt form of the phosphorylated anabolite (-)-Emtricitabine triphosphate, an active nucleoside</p>Formula:C8H9FN3Na4O12P3SPurity:98%Color and Shape:SolidMolecular weight:575.11Tobevibart
CAS:<p>Tobevibart, an IgG1-lambda humanized monoclonal antibody targeting the hepatitis B virus (HBV) surface envelope protein, exhibits antiviral activity [1].</p>Purity:98%Color and Shape:LiquidIR415
CAS:<p>IR415 selectively interacts with Hepatitis B virus X protein (HBx, Kd = 2 nM) and blocks HBV-mediated RNAi suppression, reverses the inhibitory effect of HBx</p>Formula:C13H14F2N4SPurity:99.85%Color and Shape:SolidMolecular weight:296.34Valtorcitabine dihydrochloride
CAS:<p>Valtorcitabine dihydrochloride, a DNA polymerase inhibitor, is used potentially for the treatment of HBV infection.</p>Formula:C14H24Cl2N4O5Color and Shape:SolidMolecular weight:399.27Besifovir Dipivoxil maleate
CAS:<p>Besifovir Dipivoxil maleate, an oral HBV prodrug (LB80380), suppresses HBV DNA in naive and lamivudine-resistant CHB cases.</p>Formula:C22H34N5O8PPurity:98%Color and Shape:SolidMolecular weight:527.51HBV-IN-30
CAS:<p>HBV-IN-30, a flavone derivative, inhibits cccDNA in HBV research.</p>Formula:C22H18BrClO6Color and Shape:SolidMolecular weight:493.73SHR5133
CAS:<p>SHR5133 is a potent, orally active regulator of HBV capsid assembly that reduces HBV DNA (EC50: 26.6 nM).</p>Formula:C19H18F4N6O2Color and Shape:SolidMolecular weight:438.38AB-836
CAS:<p>AB-836, an orally active hepatitis B virus (HBV) capsid inhibitor, hampers viral replication by engaging with the HBV core protein.</p>Formula:C20H15F3N4O2Color and Shape:SolidMolecular weight:400.35Lagociclovir valactate
CAS:<p>Lagociclovir valactate is a prodrug of Lagociclovir . Lagociclovir valactate is an orally active anti- HBV agent [1] .</p>Formula:C18H25FN6O6Color and Shape:SolidMolecular weight:440.43Linvencorvir
CAS:<p>Linvencorvir is a hepatitis B virus (HBV) core protein variant modifier used to treat chronic HBV infection.</p>Formula:C29H35FN6O5SPurity:99.9% - 99.9%Color and Shape:SolidMolecular weight:598.69Tenofovir amibufenamide
CAS:<p>Tenofovir amibufenamide (HS-10234) 是一种 Tenofovir 前药,是一种具有口服活性的抗病毒化合物。Tenofovir amibufenamide 对乙型肝炎病毒 (HBV)具有抑制作用,可用于慢性乙型肝炎 (CHB) 研究。</p>Formula:C22H31N6O5PPurity:99.19% - 99.87%Color and Shape:SolidMolecular weight:490.49HBV-IN-24
<p>HBV-IN-24 inhibits HBV DNA, HBsAg, HBeAg (EC50: 0.6, 0.6, 4.6 nM), and has antiviral properties with neurotoxicity mitigation.</p>Formula:C23H27NO6Color and Shape:SolidMolecular weight:413.46

